Trial intelligence / Profile preview

Post-marketing re-evaluation of Zhuifengtougu Capsules for osteoarthritis

ChiCTR2000028809Phase 4Recruiting

Sponsor
Temporarily not sure
Start
Sep 2019
Countries
1
01

Overview

Phase 4, open-label trial of zhuifengtougu in osteoarthritis (OA) (2 arms), sponsored by Temporarily not sure. Primary endpoints: Related symptoms and signs of osteoarthritis and X-ray changes. Started Sep 2019; status: recruiting.

02

Drugs

zhuifengtougu
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on ChiCTR2000028809.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000028809.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call